Back to today’s briefing

Story perspectives

Bioptimus Raises $41 Million to Revolutionize Biological AI

1/14/2025

50 12

Summary

Story summary

Bioptimus, a groundbreaking AI startup from Paris, has secured $41 million in funding, bringing its total to $76 million. With this investment, the company is set to create a universal AI model for biology that will revolutionize how researchers simulate intricate biological systems, foresee disease outcomes, and craft targeted therapies, influencing a wide range of industries beyond just pharmaceuticals.

1 of 1

Story summary

Bioptimus, a groundbreaking AI startup from Paris, has secured $41 million in funding, bringing its total to $76 million. With this investment, the company is set to create a universal AI model for biology that will revolutionize how researchers simulate intricate biological systems, foresee disease outcomes, and craft targeted therapies, influencing a wide range of industries beyond just pharmaceuticals.